| Ulbrich Family Medicine, Llc | |
|
2301 S Highway 65 Suite 2 Marshall MO 65340-3702 | |
| (660) 631-3386 | |
| Not Available |
| Full Name | Ulbrich Family Medicine, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 2301 S Highway 65, Marshall, Missouri |
| Authorized Official Name and Position | Jamie Grant Ulbrich (OWNER) |
| Authorized Official Contact | 6606313386 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ulbrich Family Medicine, Llc 2301 S Highway 65 Suite 2 Marshall MO 65340-3702 Ph: (660) 631-3386 | Ulbrich Family Medicine, Llc 2301 S Highway 65 Suite 2 Marshall MO 65340-3702 Ph: (660) 631-3386 |
| NPI Number | 1144693870 |
|---|---|
| Provider Enumeration Date | 11/03/2015 |
| Last Update Date | 12/22/2015 |
| Medicare PECOS PAC ID | 6507167509 |
|---|---|
| Medicare Enrollment ID | O20151216002232 |
News Archive
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular biology databases, is using the pan-European GÉANT research network and JANET, the UK research network, to help biologists share vital data across the globe.
The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue sarcoma is a cancer that begins in the muscle, fat, fibrous tissue, and other tissues.
A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread-a discovery that could significantly alter the way cancer drugs are evaluated in the future.
Spinal Restoration, Inc. announced today that the success criteria for primary analysis of the Phase III Investigational New Drug study of the Biostat System were not met. The proportions of successful patients that received BIOSTAT BIOLOGX Fibrin Sealant or saline injection were not statistically significantly different when analyzed at the 26-week primary endpoint.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144693870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD105523 (Missouri) | Primary |
| Provider Name | Jamie G Ulbrich |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447292776 PECOS PAC ID: 0648303057 Enrollment ID: I20100805000923 |
News Archive
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular biology databases, is using the pan-European GÉANT research network and JANET, the UK research network, to help biologists share vital data across the globe.
The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue sarcoma is a cancer that begins in the muscle, fat, fibrous tissue, and other tissues.
A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread-a discovery that could significantly alter the way cancer drugs are evaluated in the future.
Spinal Restoration, Inc. announced today that the success criteria for primary analysis of the Phase III Investigational New Drug study of the Biostat System were not met. The proportions of successful patients that received BIOSTAT BIOLOGX Fibrin Sealant or saline injection were not statistically significantly different when analyzed at the 26-week primary endpoint.
› Verified 1 days ago
News Archive
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular biology databases, is using the pan-European GÉANT research network and JANET, the UK research network, to help biologists share vital data across the globe.
The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue sarcoma is a cancer that begins in the muscle, fat, fibrous tissue, and other tissues.
A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread-a discovery that could significantly alter the way cancer drugs are evaluated in the future.
Spinal Restoration, Inc. announced today that the success criteria for primary analysis of the Phase III Investigational New Drug study of the Biostat System were not met. The proportions of successful patients that received BIOSTAT BIOLOGX Fibrin Sealant or saline injection were not statistically significantly different when analyzed at the 26-week primary endpoint.
› Verified 1 days ago
Marshall Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2305 South 65 Highway, Building A, Marshall, MO 65340 Phone: 660-886-7800 Fax: 660-831-3328 | |
Mid-missouri Family Health, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 78 S. Jefferson, Marshall, MO 65340 Phone: 660-831-1175 | |
Katy Trail - Marshall School Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 313 E Eastwood St, Marshall, MO 65340 Phone: 660-886-7100 | |
Mid Missouri Family Health At Fitzgibbon Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4 N Jefferson Ave, Marshall, MO 65340 Phone: 660-831-1175 Fax: 660-831-1195 | |
D. J. Fahnestock, D. C., P. C. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 269 S Jefferson Ave, Marshall, MO 65340 Phone: 660-886-6903 Fax: 660-886-6904 | |
Missouri Valley Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 E College St, Marshall, MO 65340 Phone: 660-831-4000 |